ArticleFrontiers in health services2025
Pioneering hospital-at-home in Taiwan: early clinical outcomes from the first cohort of nursing home older adults.
Article in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hospital at Home in 10 years-Here, borrow my binoculars.Journal of internal medicine · 2026Article
- Outpatient Parenteral Antimicrobial Therapy in Asia: Evolution, Models, and Challenges over the Past Decade-A Narrative Review.Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study provides the first empirical evaluation of Taiwan's Hospital-at-Home (HaH) pilot program, launched in 2024 under the National Health Insurance system. The aim was to examine the clinical effectiveness, safety, and economic feasibility of HaH in managing acute infections, including pneumonia, urinary tract infections (UTIs), and soft tissue infections (STIs), among older adults living in long-term care facilities. Methods: A prospective, matched-controlled study was conducted from July 2024 to June 2025 across seven nursing homes. Sixty residents aged 65 years or older who received HaH care were matched in a 1:2 ratio with 120 hospitalized patients by age, sex, and diagnosis. HaH services were delivered by a single interdisciplinary team. Primary outcomes included care duration, medical costs (USD), emergency department (ED) revisits, readmissions, and mortality. Secondary outcomes were complication rates. Statistical analyses used Chi-square tests, t-tests, and Mann-Whitney U tests, with odds ratios and 95% confidence intervals reported. A Results: HaH patients had significantly shorter care episodes compared with hospitalized patients (6.6 ± 1.5 vs. 11.8 ± 6.0 days, Conclusion: The findings demonstrate that HaH is a safe, effective, and cost-efficient alternative to hospitalization for acute infections in institutionalized older adults. By reducing care duration and costs without compromising clinical outcomes, HaH offers a patient-centered model that can ease healthcare system pressures in rapidly aging societies. These results support further expansion of HaH in Taiwan and encourage additional longitudinal studies to confirm long-term benefits and broader health system impacts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.